The Florida ASCENT Study
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Testing the Effect of Sulforaphane, a Compound Naturally Found in Cruciferous Vegetables, on Preventing Melanoma in Patients With a Prior History of Melanoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Evaluate the Safety and Efficacy of Autologous Tumor-infiltrating Lymphocyte in Patients With Refractory Melanoma Who Failed to Immune Checkpoint Inhibitors
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Clinical Genetics Branch Eligibility Screening Survey
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
IDOV-Immune for Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
PLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients
- Status
- RECRUITING
- Phase
- PHASE2
Exploratory Study of Inhaled Afatinib Dimaleate PK Profile
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
- Status
- RECRUITING
- Phase
- N/A
A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers
- Status
- TERMINATED
- Phase
- PHASE1
Review of the Literature and Serie of Patients Who Underwent Reconstruction After Wide Local Excision of Nail Apparatus for Melanoma
- Status
- RECRUITING
- Phase
- N/A
A Study to Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2
Evaluation of Hypoxia in Primary Melanoma
- Status
- RECRUITING
- Phase
- N/A
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Statins to Prevent Immune Checkpoint Inhibitor-induced PRogression of AtherosLerosis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable or Metastatic Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma
- Status
- RECRUITING
- Phase
- PHASE2